Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing metastatic prostate cancer.

S Ngan1, D Mazhar, J Waxman

  • 1Imperial College, Hammersmith Campus, London W12 0NN.

British Journal of Hospital Medicine (London, England : 2005)
|November 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extension of the intravitreal injection interval after switching to faricimab in patients with exudative AMD: The multicenter FAR WEST study.

Journal francais d'ophtalmologie·2026
Same author

Evaluating trastuzumab deruxtecan in patients with gastrooesophageal adenocarcinoma who are ctDNA and HER2 positive: DECIPHER.

ESMO gastrointestinal oncology·2026
Same author

Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancer.

Oncogene·2026
Same author

Exercise During Chemotherapy for Cancer: A Systematic Review.

Journal of surgical oncology·2024
Same author

Smoothed particle hydrodynamics implementation to enhance vertebral fracture finite element model in a cervical spine segment under compression.

Journal of the mechanical behavior of biomedical materials·2024
Same author

[Autofluorescence in a case of retinal astrocytic hamartoma].

Journal francais d'ophtalmologie·2021

Prostate cancer is a common malignancy. This review covers current treatments for metastatic prostate cancer, including hormonal therapies, chemotherapy, and emerging targeted treatments.

Area of Science:

  • Oncology
  • Urology

Background:

  • Prostate cancer is a prevalent malignancy in Western countries.
  • Androgen deprivation therapy (ADT) is a primary treatment for metastatic or recurrent prostate cancer.
  • Most patients eventually develop resistance to ADT, leading to disease progression.

Purpose of the Study:

  • To review current treatment strategies for metastatic prostate cancer.
  • To highlight advancements in hormonal therapies, chemotherapy, and management of bone disease.
  • To discuss the role of biological and targeted therapies in advanced prostate cancer.

Main Methods:

  • This is a review article.
  • Literature search on current treatment options for metastatic prostate cancer.
  • Synthesis of information on established and novel therapeutic approaches.

Related Experiment Videos

Main Results:

  • Hormonal therapies remain a cornerstone of treatment.
  • Chemotherapy is utilized for advanced or castration-resistant disease.
  • Management of bony metastases is crucial for patient quality of life.
  • Biological and targeted therapies offer new avenues for treatment.

Conclusions:

  • Metastatic prostate cancer management requires a multimodal approach.
  • Continued research is essential for improving outcomes in advanced prostate cancer.
  • Personalized treatment strategies are increasingly important.